These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 310687)

  • 1. [In vitro study on the sensitivity of various bacteria to a new antibiotic resistant to beta-lactamases].
    Conti P; Bologna M; Sciarra D; Angeletti PU
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):161-6. PubMed ID: 310687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.
    King A; Warren C; Shannon K; Phillips I
    J Antimicrob Chemother; 1980 Jul; 6(4):479-94. PubMed ID: 6253433
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro effectiveness of oral cephalosporins, ampicillin and beta-lactamase resistant cephalosporins on enterobacteriaceae].
    Baier R; Puppel H
    Ther Ggw; 1979 Mar; 118(3):317-30. PubMed ID: 311958
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory activity and resistance to hydrolysis by beta-lactamases of some (D,L)-7-(alpha-fluoroacylamino)cephalosporins.
    Somma S; Malabarba A; Gastaldo L; Cavalleri B
    Farmaco Sci; 1984 May; 39(5):463-72. PubMed ID: 6376165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefoxitin, a new semi-synthetic cephamycin (author's transl)].
    Stapley EO; Birnbaum J
    Sem Hop; 1978 Oct 8-15; 54(29-32):975-81. PubMed ID: 216093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the antibacterial action of beta-lactam antibiotics.
    Richmond MH
    J Antimicrob Chemother; 1978 Jul; 4(B):1-14. PubMed ID: 357373
    [No Abstract]   [Full Text] [Related]  

  • 19. Lysis, induced by cefoxitin sodium, of Gram-negative bacteria containing various R-factors.
    Russell AD; Tottle PC; Chapman DG
    J Antimicrob Chemother; 1978 Jul; 4(B):33-40. PubMed ID: 308501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.